Insider · CIK 0001957180
Tsveta Milanova
officer
Files at AGIO (AGIOS PHARMACEUTICALS, INC.). First filing Jan 7, 2025, latest Mar 3, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 6
$0 bought, $483k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGIO: AGIOS PHARMACEUTICALS, INC.
AGIOOct 9, 2026 · close 31.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 4Weak | AGIOS PHARMACEUTICALS, INC. | $83k 2,868 shares | -7% | +31% from low-36% from high | |
| 4Weak | AGIOS PHARMACEUTICALS, INC. | $78k 2,872 shares | -8% | +23% from low-40% from high | |
| 4Weak | AGIOS PHARMACEUTICALS, INC. | $79k 2,932 shares | -9% | +22% from low-40% from high | |
| 5Weak | AGIOS PHARMACEUTICALS, INC. | $93k 2,770 shares | -10% | +36% from low-46% from high | |
| 2Weak | AGIOS PHARMACEUTICALS, INC. | $60k 1,681 shares | -7% | +4% from low-46% from high | |
| 0Weak | AGIOS PHARMACEUTICALS, INC. | $90k 2,804 shares | -13% | +5% from low-46% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +5,666 | $0.00 | $0 | 40,459 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,681 | $28.96 | $49k | 38,778 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +4,000 | $0.00 | $0 | 42,778 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,187 | $28.96 | $34k | 41,591 | Mar 3, 2026 |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative10b5-1 | +14,000 | $0.00 | $0 | 14,000 | Mar 3, 2026 |
| Mar 1, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative10b5-1 | +52,000 | $0.00 | $0 | 52,000 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -5,666 | $0.00 | $0 | 5,667 | Mar 3, 2026 |
| Mar 2, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -4,000 | $0.00 | $0 | 8,000 | Mar 3, 2026 |
| Jan 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +8,475 | $0.00 | $0 | 37,665 | Jan 7, 2026 |
| Jan 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -2,872 | $27.02 | $78k | 34,793 | Jan 7, 2026 |
| Jan 5, 2026 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -8,475 | $0.00 | $0 | 0 | Jan 7, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +6,000 | $0.00 | $0 | 32,122 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -2,932 | $27.09 | $79k | 29,190 | Jan 2, 2026 |
| Dec 30, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -6,000 | $0.00 | $0 | 0 | Jan 2, 2026 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +6,000 | $0.00 | $0 | 28,892 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -2,770 | $33.54 | $93k | 26,122 | Jun 26, 2025 |
| Jun 24, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Performance share unitsderivative10b5-1 | -6,000 | $0.00 | $0 | 6,000 | Jun 26, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +5,667 | $0.00 | $0 | 24,573 | Mar 4, 2025 |
| Mar 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -1,681 | $35.54 | $60k | 22,892 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative10b5-1 | +12,000 | $0.00 | $0 | 12,000 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative10b5-1 | +43,500 | $0.00 | $0 | 43,500 | Mar 4, 2025 |
| Mar 1, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -5,667 | $0.00 | $0 | 11,333 | Mar 4, 2025 |
| Jan 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Common stock10b5-1 | +8,476 | $0.00 | $0 | 21,710 | Jan 7, 2025 |
| Jan 6, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | SOpen-market sale Common stock10b5-1 | -2,804 | $32.18 | $90k | 18,906 | Jan 7, 2025 |
| Jan 3, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | MOption exercise Restricted stock unitsderivative10b5-1 | -8,476 | $0.00 | $0 | 8,475 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.